The Discounted Cash Flow (DCF) valuation of Apex Medical Corp (4106.TW) is 30.53 TWD. With the latest stock price at 22.30 TWD, the upside of Apex Medical Corp based on DCF is 36.9%.
Based on the latest price of 22.30 TWD and our DCF valuation, Apex Medical Corp (4106.TW) is a buy. buying 4106.TW stocks now will result in a potential gain of 36.9%.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 7.3% | 6.1% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 20.15 - 92.61 | 30.53 |
| Upside | -9.7% - 315.3% | 36.9% |